Medullary Thyroid Cancer

Showing 1 - 25 of 33

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

Not yet recruiting
  • Adrenal Cortical Carcinoma
  • +3 more
  • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
  • Shanghai, Shanghai, China
    Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
Nov 19, 2023

A Detailed Look At What Patients Experience In Medullary Thyroid

Not yet recruiting
  • Medullary Thyroid Cancer
    • San Francisco, California
      Power Life Sciences
    Oct 6, 2023

    Medullary Thyroid Cancer Trial in China (Anlotinib Hydrochloride Capsule)

    Recruiting
    • Medullary Thyroid Cancer
    • Anlotinib Hydrochloride Capsule
    • Hefei, Anhui, China
    • +18 more
    Apr 14, 2023

    Medullary Thyroid Cancer Trial in Worldwide (Cabozantinib (XL184) 140 mg, Cabozantinib (XL184) 60 mg, Placebo tablet)

    Active, not recruiting
    • Medullary Thyroid Cancer
    • Cabozantinib (XL184) 140 mg
    • +3 more
    • St. Leonards, New South Wales, Australia
    • +49 more
    Jan 23, 2023

    Medullary Thyroid Cancer Trial in Worldwide (Selpercatinib, Cabozantinib, Vandetanib)

    Recruiting
    • Medullary Thyroid Cancer
    • Birmingham, Alabama
    • +148 more
    Jan 18, 2023

    Medullary Thyroid Cancer Trial in Cordoba, Sevilla (Pralsetinib, Cabozantinib, Vandetanib)

    Not yet recruiting
    • Medullary Thyroid Cancer
    • Cordoba, Spain
    • +1 more
    Jan 11, 2023

    RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

    Not yet recruiting
    • RET-altered Non Small Cell Lung Cancer
    • +3 more
    • Chang chun, Jilin, China
      Jinlin Province Cancer Hosipital
    Dec 21, 2022

    RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

    Active, not recruiting
    • RET-altered Non Small Cell Lung Cancer
    • +39 more
    • pralsetinib (BLU-667)
    • Phoenix, Arizona
    • +65 more
    Nov 10, 2022

    NSCLC, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (LOXO-292)

    Recruiting
    • Non-Small Cell Lung Cancer
    • +3 more
    • Scottsdale, Arizona
    • +84 more
    Oct 10, 2022

    Medullary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroid Carcinoma, Medullary Trial in Groningen (18F-PSMA-1007)

    Not yet recruiting
    • Medullary Thyroid Cancer
    • +3 more
    • Groningen, Netherlands
      University Medical Centre Groningen
    Sep 8, 2022

    Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

    Available
    • Non Small Cell Lung Cancer
    • +6 more
    • Goodyear, Arizona
    • +67 more
    Aug 17, 2022

    Solid Tumor, Medullary Thyroid Cancer Trial in China (Selpercatinib)

    Active, not recruiting
    • Solid Tumor
    • Medullary Thyroid Cancer
    • Guangzhou, Guangdong, China
    • +12 more
    May 9, 2022

    Children and Adults With Medullary Thyroid Cancer

    Recruiting
    • Medullary Thyroid Cancer
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Apr 7, 2022

      NSCLC, Medullary Thyroid Cancer, Solid Tumor Trial in Shanghai, Tianjin (SY-5007)

      Recruiting
      • Non-Small Cell Lung Cancer
      • +2 more
      • Shanghai, Shanghai, China
      • +1 more
      Mar 17, 2022

      Locally Advanced or Metastatic Medullary Thyroid Cancer, Medullary Thyroid Cancer Trial in Worldwide (Patient outreach,

      Active, not recruiting
      • Locally Advanced or Metastatic Medullary Thyroid Cancer
      • Medullary Thyroid Cancer
      • St Leonards, Australia
      • +33 more
      Oct 20, 2021

      Medullary Thyroid Cancer Trial (Ponatinib)

      Withdrawn
      • Medullary Thyroid Cancer
      • (no location specified)
      Oct 6, 2021

      NSCLC, Medullary Thyroid Cancer Trial (pralsetinib (BLU-667))

      Approved for marketing
      • Non-Small Cell Lung Cancer
      • Medullary Thyroid Cancer
      • pralsetinib (BLU-667)
      • (no location specified)
      Aug 9, 2021

      Medullary Thyroid Cancer Trial in France (18F-DOPA)

      Completed
      • Medullary Thyroid Cancer
      • 18F-DOPA
      • Bordeaux, France
      • +4 more
      Mar 5, 2021

      Thyroid Neoplasia, Well-Differentiated Thyroid Cancer, Medullary Thyroid Cancer Trial in São Paulo (Laser ablation,

      Recruiting
      • Thyroid Neoplasia
      • +3 more
      • Laser ablation
      • +2 more
      • São Paulo, Brazil
        Instituto do Cancer do Estado de São Paulo
      Feb 23, 2021

      Amyloid Proteins From Medullary Thyroid Cancer and Laryngeal

      Not yet recruiting
      • Amyloid
      • +3 more
        • (no location specified)
        Feb 15, 2021

        18F-Fluorocholine PET/CT in Medullary Thyroid Cancer

        Active, not recruiting
        • Medullary Thyroid Cancer
        • 18F-fluorocholine PET/CT
        • Ljubljana, Slovenia
          Department for nuclear medicine, University medical centre Ljubl
        Nov 3, 2020

        Medullary Thyroid Cancer, Colon Cancer Trial in New York (Tumor Genomic Analysis)

        Suspended
        • Medullary Thyroid Cancer
        • Colon Cancer
        • Tumor Genomic Analysis
        • New York, New York
          Icahn School of Medicine at Mount Sinai
        Oct 14, 2020

        Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)

        Terminated
        • Malignant Melanoma
        • +7 more
        • Gilbert, Arizona
        • +29 more
        Sep 21, 2020

        Carcinoid Cancer, Neuroendocrine Tumors, Medullary Thyroid Cancer Trial in Los Angeles (68Ga DOTATATE)

        No longer available
        • Carcinoid Cancer
        • +3 more
        • 68Ga DOTATATE
        • Los Angeles, California
          UCLA Hospital
        Jul 23, 2020